Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Atara BiotherapeuticsReplimune GroupAptose BiosciencesGENFIT S A/ADRMeiraGTx
SymbolNASDAQ:ATRANASDAQ:REPLNASDAQ:APTONASDAQ:GNFTNASDAQ:MGTX
Price Information
Current Price$7.70$11.17$6.16$16.58$12.42
52 Week RangeBuyBuyBuyBuyBuy
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyBuy
Consensus Price Target$29.88$24.10$12.00$51.25$38.33
% Upside from Price Target287.99% upside115.76% upside94.81% upside209.11% upside208.64% upside
Trade Information
Market Cap$441.04 million$403.00 million$465.19 million$625.71 million$496.70 million
Beta2.512.611.77N/A1.97
Average Volume699,742102,8401,045,63550,803123,516
Sales & Book Value
Annual RevenueN/AN/AN/A$8.85 million$13.29 million
Price / SalesN/AN/AN/A70.8834.41
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value$5.37 per share$4.36 per share$1.23 per shareN/A$5.22 per share
Price / BookN/AN/AN/A2.38
Profitability
Net Income$-290,980,000.00$-30,830,000.00$-26,280,000.00$-93,910,000.00$-54,750,000.00
EPS($5.67)($1.33)($0.52)N/A($1.65)
Trailing P/E RatioN/AN/AN/A0.00N/A
Forward P/E RatioN/AN/AN/AN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/A-411.84%
Return on Equity (ROE)-103.42%-29.68%-61.63%N/A-33.20%
Return on Assets (ROA)-89.08%-24.86%-55.07%N/A-19.00%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.05%0.20%N/AN/A0.11%
Current Ratio7.43%13.43%17.83%N/A5.47%
Quick Ratio7.43%13.43%17.83%N/A5.47%
Ownership Information
Institutional Ownership PercentageN/A60.10%40.26%2.82%45.28%
Insider Ownership Percentage7.00%63.18%7.34%N/A17.40%
Miscellaneous
Employees32162N/A14868
Shares Outstanding58.57 million36.65 million76.26 million37.83 million36.82 million
Next Earnings Date5/14/2020 (Estimated)6/26/2020 (Estimated)5/5/2020 (Estimated)N/A5/12/2020 (Estimated)
OptionableOptionableNot OptionableOptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel